Atlas Trials

POEMS Syndrome

14 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch POEMS Syndrome

RecordFirmDate
A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis (NCT05263817)Zhejiang University2021-10-08
Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System (NCT04561557)Tongji Hospital2020-09-22
Treatment of POEMS Syndrome With Daratumumab (NCT04396496)University of Arkansas2020-09-22
Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome (NCT02921893)Mayo Clinic2016-10-31
Efficacy and Safety of Lenalidomide as a Treatment for Recurrent or Refractory POEMS Syndrome Trial (NCT02193698)Chiba University2014-07-01
Study to Evaluate Lenalidomide Plus Dexamethasone in Patients With Newly Diagnosed POEMS Syndrome (NCT01816620)Peking Union Medical College Hospital2014-03-01
POEMS Syndrome Treatment With Lenalidomide (NCT01639898)University Hospital, Limoges2012-07-01
The Treatment of Lenalidomide in Patients With POEMS Syndrome (NCT00971685)Istituto Clinico Humanitas2009-07-01

Track POEMS Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.